TFO Wealth Partners’s Labcorp LH Stock Holding History

TFO Wealth Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-33	Closed	-$7K	–	327
2022 Q2	$7K	Buy	+33	New	+$7.03K	﹤0.01%	172

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

TFO Wealth Partners's LH Position: Q3 2022 in Review

TFO Wealth Partners sold out of Labcorp (LH) in Q3 2022, closing a stake of 33 shares — an estimated $7K sold.

TFO Wealth Partners first reported a position in LH in Q2 2022 and held it in 1 quarter. The position peaked at $7K in Q2 2022. 936 funds tracked by Wall St. Rank hold LH as of Q3 2022.

TFO Wealth Partners reported no remaining Labcorp position as of Q3 2022 after selling out during the quarter.
TFO Wealth Partners sold 33 Labcorp shares in Q3 2022, an estimated $7K.
TFO Wealth Partners first reported a position in Labcorp in Q2 2022 and held it in 1 quarter.
TFO Wealth Partners's Labcorp position peaked at $7K in Q2 2022.
936 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on TFO Wealth Partners's 13F filing for Q3 2022, filed 8 Nov 2022.